1. Japan Stocks

  2. •

    Basic Materials

  3. •

    Chemicals
Nihon Seiko Co., Ltd.

Nihon Seiko Co., Ltd.

5729.T
Nihon Seiko Co., Ltd.JP flagTokyo Stock Exchange
1,536.00
JPY
+3.00
- -
15.06BMarket Cap
Nihon Seiko Co., Ltd.
5729.T
(Tokyo Stock Exchange)

Recent

price

1,536.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
724.65
1,108.76
1,330.64
1,193.99
1,233.39
1,347.47
1,207.46
1,178.24
1,487.67
1,442.4
1,117.84
1,152.14
1,751.52
1,631.26
1,595.74
2,573.25
788.5
Revenue per Share
-9.54
69.83
64.88
39.41
40.52
61.72
32.03
66.02
97.39
84.98
29.31
83.35
157.86
49.36
51.46
251
34.92
Basic EPS, GAAP
80.91
-48.3
-109.27
10.37
96.64
29.65
86.43
45.58
43.84
55.96
81.43
91.84
-26.62
-57.23
-1.73
-158.54
- -
Free Cash Flow per Basic Share
2.51
7.5
15
12.5
12.5
12.5
15
12.5
14.44
18.75
18.75
15.63
22.5
37.5
24.99
25
- -
Dividend per Share
249.88
318.53
368.59
396.64
424.73
473.23
490.33
439.68
625.86
692.22
702.85
770.64
906.04
917.93
943.65
1,168.14
995.26
Book Value per Share
288.6
358.13
404.27
431.28
460.7
511.38
528.23
584.34
669.56
733.31
741.53
807.71
941.19
948.54
977.21
1,205.55
1,031.47
Tangible Book Value per Share
10
10
10
10
10
10
10
10
10
10
10
10
10
10
10
10
10
Basic Weighted Avg Shares
7,290
10,879
13,048
11,672
12,055
13,167
11,798
11,511
14,529
14,084
10,914
11,247
17,098
15,923
15,589
25,180
7,705
Sales/Revenue/Turnover
6.62
9.91
9.38
7.28
7.29
8.94
6.44
8.4
9.78
8.89
4.11
10.62
12.82
5.04
4.33
14.29
6.06
Operating Margin (%)
234
248
241
446
484
446
410
425
420
472
456
414
459
531
523
672
- -
Depreciation Expense
-96
685
636
385
396
603
313
645
951
830
286
814
1,541
482
503
2,456
341
Net Income, GAAP
131.29
19.07
31.57
36.96
38.61
37.62
36.64
32.32
31.59
31.73
33.76
31.28
31.33
39.03
27.51
30.43
27.56
Effective Tax Rate (%)
-1.32
6.3
4.88
3.3
3.28
4.58
2.65
5.6
6.55
5.89
2.62
7.23
9.01
3.03
3.22
9.75
4.43
Profit Margin (%)
2,627
2,034
2,139
2,560
2,761
2,898
2,245
2,832
3,368
3,782
3,680
4,171
5,283
5,362
5,476
7,431
5,973
Working Capital
1,230
842
1,739
2,094
2,044
1,462
960
938
708
470
240
234
605
616
1,496
1,009
994
LT Debt
2,926
3,540
4,015
4,282
4,562
5,057
5,213
5,755
6,581
7,206
7,286
7,966
9,299
9,409
9,701
11,933
10,224
Total Equity
-2.57
14.34
11.65
6.58
6.32
8.52
5.67
7.75
10.93
9.13
3.21
8.71
13.89
4.19
3.99
16.7
2.63
Return on Invested Capital (%)
-2.1
13.22
10.15
5.48
5.26
7.85
4.22
8.98
12.6
9.71
3.39
9.33
15.61
4.5
4.42
17.91
2.86
Return on Capital (%)
-3.73
24.3
18.88
10.28
9.86
13.75
6.65
14.2
18.28
12.89
4.2
11.31
18.83
5.41
5.53
23.79
3.65
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
1,607
- -
2,356
LT Borrowings
1,192
- -
994
LT Finance Leases
304
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
10
- -
10
Market Capitalization
24,019
29,264
28,926

Working Capital

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
9,706
- -
11,289
Cash, Cash Equivalents & STI
3,023
- -
2,221
Accounts Receivable, Net
2,867
- -
3,829
Inventories
3,549
- -
4,987
Total Current Liabilities
4,230
- -
5,316
Payables & Accruals
- -
- -
- -
ST Debt
1,607
- -
2,356
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.18%
10.67%
23%
Free Cash Flow
919.98%
1,797.26%
9,084.5%
Net Income, GAAP
62.5%
119.57%
388.54%
Sales/Revenue/Turnover
9.54%
21.53%
61.52%
Total Cash Common Dividend
10.94%
12.17%
0.18%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3,800
4,084
3,636
4,070
15,589
2025
- -
- -
- -
- -
25,180
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2.29
- -
- -
- -
51.46
2025
- -
- -
- -
- -
251
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
24.99
2025
- -
- -
- -
- -
25
2026
- -
- -
- -
- -
- -
Similar Companies
Kolon Life Science Inc. (102940.KQ)
PT Samator Indo Gas Tbk (AGII.JK)
Ellenbarrie Industrial Gases Ltd (ELLEN.NS)
Skotan S.A. (SKT.WA)
Dongnam Chemical Co., Ltd. (023450.KS)
Bhansali Engineering Polymers Limited (BEPL.NS)
Business
Nihon Seiko Co., Ltd. manufactures and sells antimony products and atomized metal powders primarily in Japan; antimony trioxide and special treatment variants including masterbatches, wet type, and water dispersion type serve as flame-retardant additives for plastics and rubbers and as polyester polymerization catalysts; antimony trisulfide functions as a solid lubricant in brake pads; sodium antimonate acts as a flame-retardant additive for engineering plastics; antimony metal supports alloys and semiconductor raw materials; the company also produces metal sulfides such as tin sulfides and copper sulfides for solid lubricants and friction materials, alongside sales of complex flame-retardants and other metal powders. Through its subsidiary Nippon Atomized Metal Powders Corporation, Nihon Seiko supplies copper, silver, and precious metal powders for conductive pastes in electronic devices like MLCCs, inductors, and LTCCs; soft magnetic alloy powders for powder inductors in power supplies including DC-DC converters; and bronze and brass powders for motor and automotive bearings produced via proprietary water atomization technology. Founded in 1935 and headquartered in Tokyo, Japan, with principal operations including the Nakase Refinery in Hyogo Prefecture, Osaka Sales Office, and subsidiaries in Chiba Prefecture and Shanghai, China, the company operates in the specialty chemicals and advanced materials segments targeting automotive, electronics, telecommunications, and industrial markets across Japan and select international regions. In recent developments, Nihon Seiko completed acquisition of full ownership of Nippon Atomized Metal Powders Corporation in 2008, established the Tsukuba Plant in Ibaraki in 2012, and reported consolidated net sales of 25,179 million yen for fiscal year 2025, reflecting ongoing focus on production enhancements and financial transparency through regular investor relations updates.